fidexaban has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abendschein, DR; Baum, PK; Eisenberg, PR; Light, DR; Martin, DJ; Post, J; Rumennik, G; Sullivan, ME; Vergona, R | 1 |
| Hicks, GW; Janiczek-Dolphin, N; Juneau, PL; Leadley, R; McClanahan, TB; Mertz, TE; Morrison, AL; Morser, J; Peng, YW; Sullivan, ME | 1 |
| Chi, L; Gallagher, K; Gibson, G; Hicks, G; Janiczek, N; Juneau, PL; Leadley, R; Mertz, TE; Pen, YW; Potoczak, R | 1 |
3 other study(ies) available for fidexaban and Disease Models, Animal
| Article | Year |
|---|---|
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
Topics: Amidines; Animals; Anticoagulants; Antithrombin III; Arthropod Proteins; Coronary Thrombosis; Disease Models, Animal; Female; Intercellular Signaling Peptides and Proteins; Male; Naphthalenes; Peptides; Propionates; Pyridines; Rabbits; Species Specificity; Venous Thrombosis | 2000 |
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
Topics: Amidines; Animals; Anticoagulants; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrolysis; Enoxaparin; Factor Xa Inhibitors; Partial Thromboplastin Time; Prothrombin Time; Pyridines; Thrombin Time; Thrombosis; Time Factors; Venous Thrombosis | 2001 |
Assessment of ex vivo pharmacodynamic markers during inhibition of thrombosis by CI-1031 (ZK-807834), a novel direct factor Xa inhibitor.
Topics: Amidines; Animals; Anticoagulants; Biomarkers; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Pyridines; Rabbits; Venous Thrombosis | 2002 |